After FDA replaces review panel, peptide products flagged as risky still get approved
A scientific review panel unanimously flagged seven popular peptides as unsafe, but RFK's replacement committee nearly unanimously approved them—laying bare the gap between regulatory science and political appointment.
The video won't play here. Listen to the audio instead:
The argument · tap a timestamp to hear it
The word "peptide" itself is meaningless
Peptide is chemically just "a chain of amino acids"—oxytocin, insulin, most hormones and neurotransmitters are all peptides. The speaker finds the term's overuse deeply frustrating because asking "do you eat peptides" is meaningless, like asking "do you eat molecules." The real questions should be about which specific peptide, whether there is human safety data, and whether this dose and route have been researched, not treating a chemical classification as a unified wellness concept.
Peptide drugs have been in medical use for a century
Humans first used peptides as medicine in 1921 with insulin, extracted from cow and pig pancreas, saving millions of lives. Scientists cracked synthetic peptides in the 1950s, with another breakthrough in 1984—both won Nobel prizes in chemistry. By 2021 FDA had approved 80 peptide drugs for diabetes, weight loss, osteoporosis, cancer, HIV, and multiple sclerosis. The novelty is not that "peptides work as medicine"—it is that the versions now sold online never went through this approval process.
Unregulated peptide market ads grew eightfold in four years
These peptides sold via WhatsApp, direct from Chinese factories, labeled "for research use only" are neither prescription drugs nor compliant supplements—pure gray market. The New York Times reported that web ads for unauthorized peptide products grew eightfold from 2022 to 2024. An industry report valued the 2022 global peptide market at $37.8 billion, projected to grow 9% annually and reach $85.9 billion by 2031—a multi-billion-dollar industry that skipped clinical trials and FDA approval.
GLP-1's success created a halo effect for all peptides
Semaglutide and tirzepatide are themselves peptides, and their weight-loss success brought "peptide" into mass consciousness for the first time. The halo effect: once you see benefits in one domain, you assume they exist everywhere, so "this new peptide is amazing" expands to "all peptides are worth trying." GLP-1 drugs also normalized self-injection as a path to self-improvement. Early scarcity pushed people to buy outside legitimate channels, paving the way for the gray market.
Experts unanimously warned against these peptides; the committee approved them anyway
In 2023 FDA removed 12 peptides from the "503A bulks list" (which compounding pharmacies can use) due to insufficient safety evidence. RFK Jr. tweeted about ending FDA's "oppression" of peptides; after becoming HHS secretary, he replaced 8 members of the committee responsible for reviewing this list. At July's hearing, the scientific review panel raised significant safety concerns about all 7 re-examined peptides and found insufficient efficacy evidence for any. Yet all but one were voted back onto the list—votes almost always 8 in favor, 6 opposed, 1 abstaining.
Wolverine stack has zero human data and cancer-promoting mechanisms
The most popular combo, "Wolverine stack," consists of BPC-157 and TB-500, claimed to accelerate recovery. Neither has real human safety data—BPC-157 has only one small 17-person study, TB-500 has zero human research and no toxicity data. More troubling: TB-500 derives from TB4, which promotes blood vessel growth, cell proliferation, and blocks cell death—precisely what tumors excel at. People are literally injecting themselves with potentially cancer-promoting compounds.
Barbie peptide has already caused cancer and muscle breakdown
Melanotan-2, called "Barbie peptide," claims to darken skin and boost libido by stimulating melanin receptors, directly activating skin-cancer-related pathways. It has already caused cancer in at least two reported cases, plus rhabdomyolysis and kidney infarction. At a Las Vegas wellness expo, people injecting unknown peptides were hospitalized; one was intubated. These are not hypothetical risks—they are documented cases of real harm already recorded in medical literature.
When the patent became public, counterfeits flooded the gray market
Retatrutide is Eli Lilly's Phase 3 drug targeting three weight-loss hormones with impressive clinical data. Because clinical data is published and patents are public, the amino acid sequence is findable; companies copied it and sold it on the gray market. Buyers do not know if they are getting the real thing or correct doses. People are rapidly losing weight on counterfeit unapproved drugs with no doctor supervision—explicitly described as extremely dangerous.
In their own words · checked verbatim
If you work for the FDA and are part of this corrupt system, I have two messages for you. One, preserve your records. And two, pack your bags. Thank you.
Robert F. Kennedy Jr.0:00
Like, the word peptide does not mean what people are meaning it as.
people are buying these peptides that are specifically labeled not for human use or for research use only.
The halo effect is this idea in psychology that if you see a benefit in one area, then you're going to assume that there's a bigger benefit in everything.
And in every single case except one, the panel decided to add them to the list regardless.
If you can start replicating yourselves really quickly, you can also just quickly grow cancer.
Up to 40% of the time, it is not what it claims to be in the vial.
It is actually offensive. It is deeply offensive, that idea that something, just because our body makes it, is not harmful to inject.
Figures
| FDA-approved peptide drugs (as of 2021) | 80 | 14:45 |
| Unauthorized peptide product web ad growth (2022–2024) | 8x | 19:57 |
| Global peptide market size (2022) | $37.8 billion | 19:57 |
| Projected peptide market annual growth rate | 9% | 19:57 |
| Projected global peptide market size (2031) | $85.9 billion | 19:57 |
| FDA review panel members replaced by RFK | 8 | 30:10 |
| Seven-peptide hearing vote outcome (typical) | 8 in favor, 6 opposed, 1 abstaining | 33:13 |
| Gray market peptide counterfeit rate | up to 40% | 48:47 |
| Single gray market peptide vial price | hundreds of dollars | 55:53 |
| Influencer peptide spending example | $25,000 | 55:53 |
Glossary
- GLP-1
- Glucagon-like peptide-1, a hormone that regulates blood sugar and appetite; the target of weight-loss drugs like semaglutide.
- compounding pharmacy
- A pharmacy that can custom-prepare medications per prescription, subject to lower regulatory standards than pharmaceutical manufacturers.
- 503A bulks list
- FDA's list of substances that compounding pharmacies are permitted to use in custom preparations.
- halo effect
- Cognitive bias where perceiving one positive trait causes you to assume all related things are positive.
- acromegaly
- A disease caused by excess growth hormone, characterized by ongoing growth of bones and internal organs.
How to listen
Anyone interested in anti-aging, muscle-building, or considering peptide injections, plus those who want to understand how regulation gets lobbied around.
Opening cocktail-party banter (approx. 3:27–5:30) has low information density and can be skipped.